Early protective effects of lloprost after experimental spinal cord injury

Neurological Research

Volumn 20, Issue 4, 1998, Pages 353-359

  Attar, Ayhan ^a   Tuna, Hakan ^a   Sargon, Mustafa F ^b   Yüceer, Nurullah ^a   Türker, R Kazim ^a   Egemen, Nihat ^a,c  

^a ANKARA UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Experimental model; Lloprost; PGI2; Prostocyclin analogue; Spinal cord trauma

Indexed keywords

ILOPROST; PROSTACYCLIN DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EVOKED RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROPROTECTION; NONHUMAN; RABBIT; SPINAL CORD INJURY;

EID: 0031861978     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1080/01616412.1998.11740531     Document Type: Article

References (40)

1. Tator CH. Review of experimental spinal cord injury with emphasis on the local and systemic circulatory effects. Neurochirurgie 1991; 37: 291-302
2. Hadley MN, Browner LM, Sonntag VKH. Axis fractures. A comprehensive review of management and treatment in 107 cases. Neurosurgery 1985; 17: 281-290
3. Egemen N, Birler K, Avman N, Türker RK. Experimental cerebral vasospasm: Resolution by iloprost. Acta Neurochir 1988; 95: 131-135
4. Dohrmann GL, Wagner FC, Bucky PC. The microvasculature in transitory traumatic paraplegia. An electron microscopic study in the monkey. J Neurosurg 1971; 35: 263-271
5. 2 induction and protection with antioxidants. Neuro Chem Pathol 1983; 1: 249-264
6. Balantine JP. Pathology of experimental spinal cord trauma. II. Ultrastructure of axons and myelin. Lab Invest 1978; 39: 254-266
7. Marciano FF, Greene AK, Apostolides JP, Dickman AC, Sonntag VKH. Pharmacologic management of spinal cord injury. Review of the literature. BNI Quarterly 1995; 11: 2-11
8. Mitchell R, Fleetwood Walker S. Substance P, but not TRH, modulates the 5HT neuroreceptor in ventral lumbal spinal cord. Eur J Pharmacol 1981; 76: 119-120
9. Anderson DK, Demediuk D, Saunders RD, Dugen LL, Means ED. Spinal cord injury and protections. Annal Emergency Med 1985; 14: 816-821
10. Dohrman GL, Wagner FC, Bucy PC. Transitory traumatic paraplegia: Electron microscopy of early alterations in myelinated nerve fibers. J Neurosurg 1972; 36: 407-415
11. Ducker TB, Kindt GW, Kempe LG. Pathological findings in acute experimental spinal cord trauma. J Neumsurg 1971; 5: 700-708
12. Ducker TB. Local tissue oxygen and blood flow in the acutely injured spinal cord. Proc 18th VA Spinal Injury Conf. New York: Veterans Administration Hosp, 1971: pp. 29-32
13. Demopoulos HB, Flamm ES, Pietronigro DD, Seligman MK. The free radical pathology and the microcirculation in the major central nervous system disorders. Acta Physiol Scand (Supply) 1980; 492: 91-119
14. Egemen N, Turker RK, Sanlidilek U, Zorlutuna A, Bilgiç S, Bas(Combining ogonek)kaya MK, Unlu A, Çaǧlar S. The effect of Iloprost on severe chronic vasospasm. Proc Int Conf Cerebral Vasospasm, Tokyo, Japan, 1990
15. Ferrari R, Cargnoni A, Ceconi C, Curella S, Belloli S, et al. Protective effect of prostacyclin mimic on the ischeamic-reperfused rabbit myocardium, J Mol Cell Cardiol 1988; 20: 1095-1106
16. Freeman LN, Wright TW. Experimental observations of concussion and contusion of the spinal cord. Ann Surg 1953; 137: 433-443
17. Griffiths IR. Spinal cord blood flow after acute experimental cord injury in dogs. J Neurol Sci 1976; 27: 247-259
18. Young W, Flamm ES. Effect of high dose corticosteroid therapy on blood flow, evoked potentials and extracellular calcium in experimental spinal cord injury. J Neurosurg 1982; 57: 667-673
19. Calenoff L, Chessane JW, Rogers LF, et al. Multiple level spinal injuries: Importance of early recognition. AJR 1978; 130: 665-669
20. de la Torne JC, Johnson CM, Harris LH, Kajihara K, Mullan S. Monoamine changes in experimental head and spinal cord trauma. Failure to confirm previous observations. Surg Neurol 1974; 2: 5-11
21. Sieajo BK. Cerebral circulation and metabolism. J Neurosurg 1974; 60: 883-908
22. Türker RK, Aksulu HE, Ercan ZS, Asian S. Thrombaxane A2 inhibitors and iloprost prevent angiotensin II induced oedema in the isolated perfused rat lung. Arch Internat Pharmacodynamie Therapie 1987; 287: 323-329
23. Witt W, Muller B. Antithrombotic profile of iloprost in experimental models of in vivo platelet aggregation and thrombosis. Adv Prostacyclin, Thrombaxane Leukotriene Res 1987; 17: 607-616
24. Sturzebecher CS, Loster W. Effect of Iloprost on platelet activation in vitro. In: Gryglewski RJ and Stock G, eds. Prostacyclin and its Stable Analogue Iloprost, Berlin: Springer-Verlag, 1987: pp. 39-45
25. Warso MA, Lands WEM. Pathophysiological modulation of arachidonate metabolism. Clin Physiol Biochem 1984; 2: 70-77
26. Ames A, Wright RC, Kowada M, et al. Cerebral ischemia. II. The noroflow phenomenon. Am J Pathol 1968; 52: 437-453
27. Bresnehen JC, King JS, Martin GF, et al. A neuroanatomical analysis of spinal cord injury in the rhesus monkey. J Neurol Sci 1976; 28: 521-542
28. Croft TJ, Brodkey JS, Nulsen FE. Reversible spinal cord trauma: A model for electrical monitoring of spinal cord function. J Neurosurg 1972; 36: 401-406
29. Rivlin AS, Tator CH. Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surg Neurol 1978; 10: 39-43
30. Faden AL, Jacops TP, Smith MT, et al. Comparison of thyrotropin releasing hormone (TRH), naloxane and dexamethasone treatments in experimental spinal cord injury. Neurology 1983; 33: 673-678
31. Raichle MG. The pathophysiology of brain ischemia. Ann Neurol 1983; 13: 2-10
32. Rosenblum WI. Constricting effect of leukotriens on cerebral arterioles of mice. Stroke 1985; 16: 262-263
33. Donagy RMP, Numoto M. Prognostic significance of sensory evoked potential in spinal cord injury. Proc 17th VA Spinal Cord Injury Conf, New York: Veterans Administration Hosp, 1969: pp. 251-257
34. Simpson RK, Blackburn JG, Martin HF, Katz S. Peripheral nerve fiber and spinal cord pathway contributions to the somatosensory evoked potential. Exp Neurol 1981; 73: 700-715
35. Simpson RK, Blackburn JG, Martin HF, Katz S. The effect of spinal cord injury on somatosensory evoked potentials produced by interactions between afferent pathways. Neurol Res 1983; 5: 39-56
36. Bursch W, Taper HS, Somer MP, Putz B, et al. Histochemical and biochemical studies on the effect of the prostacyclin derivative Iloprost on CCL4-induced lipid peroxidation in rat liver and its significance for hepatoprotection. Hepatology 1989; 9: 830-838
37. Bugiardini R, Galvani M, Ferrini D, Gridelli C, Tollemeto D, et al. Myocardial ischemia during intravenous prostacyclin administration: Hemodynamic findings and precautionary measures. Am Heart J 1987; 113: 234-240
38. Ferrari R, Cargnoni A, Curello S, Boffa GM, Ceconi C. Effect of Iloprost (ZK 36374) on glutathione status during ischemia and reperfusion of rabbit isolated hearts. Br J Clin Pharmacol 1989; 98: 678-684
39. Musial J, Wilczynsnska M, Sladek K, Cierniewski CS, Nizankowski R, et al. Fibrinolytic activity of prostacyclin and iloprost in patients with peripheral arterial disease. Prostaglandins 1986; 31: 61-71
40. Türker RK, Egemen N, Deda H. Cerebral vasospasm. Resolution by iloprost, Nucloprost and UK 38485. Prostaglandin in Clinical Research Cardiovascular System, New York: Alan R. Riss Inc, 1989: pp. 205-209